C4X Discovery (LON:C4XD) Shares Pass Below Fifty Day Moving Average of $11.57

C4X Discovery Holdings plc (LON:C4XDGet Free Report)’s stock price passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 11.57 ($0.15) and traded as low as GBX 8.30 ($0.10). C4X Discovery shares last traded at GBX 12 ($0.15), with a volume of 3,770,459 shares trading hands.

C4X Discovery Stock Performance

The company has a market capitalization of £30.27 million, a price-to-earnings ratio of 300.00 and a beta of 0.23. The company has a debt-to-equity ratio of 1.05, a current ratio of 15.31 and a quick ratio of 9.82. The stock has a 50 day simple moving average of GBX 11.57 and a two-hundred day simple moving average of GBX 11.61.

Insider Activity

In other C4X Discovery news, insider Clive Dix bought 485,320 shares of the firm’s stock in a transaction that occurred on Monday, April 8th. The stock was purchased at an average price of GBX 10 ($0.13) per share, for a total transaction of £48,532 ($61,386.29). Company insiders own 27.13% of the company’s stock.

C4X Discovery Company Profile

(Get Free Report)

C4X Discovery Holdings plc operates as drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules.

Featured Stories

Receive News & Ratings for C4X Discovery Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C4X Discovery and related companies with MarketBeat.com's FREE daily email newsletter.